₹ 1.8 Cr
Volume Transacted
(Nov 22, 2024)
0.6 K
Stocks Traded
(Nov 22, 2024)
Last Updated on: Nov 25, 2024
Abbott India Ltd
NSE: ABBOTINDIA
ISIN
INE358A01014
Last updated on: Nov 25, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Abbott India Ltd
NSE: ABBOTINDIA
Share Price
₹ 27699.7
554.45 (2.04%)
Last updated on: Nov 22, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
22 Nov 2024 | 27699.7 | 27180.75 | 27754.85 | 27120.65 |
21 Nov 2024 | 27145.25 | 27112.15 | 27218.85 | 26926.35 |
19 Nov 2024 | 27193.8 | 27430.9 | 27472.15 | 27133.9 |
18 Nov 2024 | 27160.8 | 27420 | 27466.75 | 27040 |
14 Nov 2024 | 27347 | 27600.45 | 27891.9 | 27235 |
13 Nov 2024 | 27644.55 | 28285.35 | 28498.45 | 27555.6 |
12 Nov 2024 | 28612.35 | 28829.05 | 29118.65 | 28571.3 |
11 Nov 2024 | 28701.5 | 28600 | 28800.2 | 28366 |
08 Nov 2024 | 28572.15 | 28283.55 | 28900 | 28066 |
07 Nov 2024 | 28291.25 | 29185.95 | 29390 | 28040.75 |
Date | Price (₹) |
---|---|
22 Nov 2024 | 27699.7 |
21 Nov 2024 | 27145.25 |
19 Nov 2024 | 27193.8 |
18 Nov 2024 | 27160.8 |
14 Nov 2024 | 27347 |
13 Nov 2024 | 27644.55 |
12 Nov 2024 | 28612.35 |
11 Nov 2024 | 28701.5 |
08 Nov 2024 | 28572.15 |
07 Nov 2024 | 28291.25 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Last updated time: 25 Nov 9.00 AM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Abbott India Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Abbott India Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Board of Abbott India appoints director
The Board of Abbott India at its meeting held on 07 November 2024 has approved the appoint...
07 Nov 202415:16
Abbott India to announce Quarterly Result
Abbott India will hold a meeting of the Board of Directors of the Company on 7 November 20...
29 Oct 202412:27
Abbott India director resigns
Abbott India announced the resignation of Ashok Saini as Commercial Director - GenNext, Va...
18 Oct 202412:03
Abbott India joins hand with Takeda Pharma to launch Vonoprazan tablets in India
Vonoprazan (PCAB or potassium competitive acid blocker) addresses severe acid related diso...
20 Sep 202410:37
Abbott India to declare Quarterly Result
Abbott India will hold a meeting of the Board of Directors of the Company on 7 August 2024...
30 Jul 202417:09
Abbott India appoints director
Abbott India has appointed Alison Davies (DIN: 10658884) as an Additional Non-Executive Di...
12 Jun 202417:57
Unlimited trading at just
Rs. 199*